Beschreibung
Sertraline and sumatriptan may interact to increase serotonergic tone, raising the theoretical risk of serotonin syndrome.
Mechanismus
Sertraline inhibits serotonin reuptake (SERT); sumatriptan is a 5-HT1B/1D agonist, and combined serotonergic stimulation may be sufficient to produce serotonin toxicity.
Klinische Bedeutung
Most clinical evidence suggests the absolute risk is low when triptans are used at recommended doses, but post-marketing cases are documented.
Maßnahmen
Combination is commonly encountered; use the lowest effective triptan dose and monitor for serotonin syndrome symptoms.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.